Publications by authors named "F Majois"

Claim this Profile
B
Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma.
Lore Decoster, Isabelle Vande Broek, Bart Neyns, Françoise Majois, Jean François Baurain

Anticancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer.
Arlene Chan, Pier-Franco Conte, Lubos Petruzelka, Nicole Tubiana-Mathieu, Vinod Ganju, Françoise Majois

Anticancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of percutaneous radiofrequency ablation for pulmonary malignancies in the hands of the surgeon.
A Hublet, E Wijtenburg, M Lismonde, T Thomas, F Majois

Acta Chir Belg· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial.
N Tubiana-Mathieu, P Bougnoux, D Becquart, A Chan, P-F Conte, F Majois

Br J Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC).
Rosa Giuliani, Virginie Durbecq, Angelo Di Leo, Marianne Paesmans, Denis Larsimont, Françoise Majois

Eur J Cancer· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis